Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 403

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1C
Chunk 403
---
 $4.125 per Unit, with each Unit consisting of (a) one share of
the Company’s Class A common stock and (b) one warrant (each, a “Warrant” and collectively, the “Warrants”)
to purchase one share of Class A common stock at an exercise price equal to $6.50 per share, exercisable until the fifth anniversary
of the issuance date, pursuant to that certain underwriting agreement dated as of September 28, 2023 (the “Underwriting Agreement”)
by and between the Company and Kingswood, a division of Kingswood Capital Partners, LLC, as representative of the several underwriters
named in the Underwriting Agreement (the “Representative”). The Company received gross proceeds of approximately $6.7 million
from the sale of the Units before deducting underwriting discounts, commissions and offering expenses. In addition, pursuant to the Underwriting
Agreement, the Company granted the Representative a 45-day option to purchase up to 242,250 Units at the initial public offering price,
less the underwriting discount, to cover over-allotments, if any (the “Over-Allotment Option”). On the Closing Date, the
Company issued an additional 242,500 Warrants to the underwriters pursuant to the partial exercise by the underwriters of the Over-Allotment
Option, generating gross proceeds of $2,422.

-32-

On
September 11, 2024, the Company completed a public offering of an aggregate of (i) 3,203,125 shares of Class A common stock of the Company,
par value $0.001 per share (the “Common Stock”), (ii) eighteen-month warrants (the “Series A Warrants”) to purchase
up to an aggregate of 3,203,125 shares of Common Stock at an exercise price of $0.64 per share, and (iii) five-year warrants (the “Series
B Warrants” and, together with the Series A Warrants, the “Warrants”) to purchase up to an aggregate of 3,203,125 shares
of Common Stock at an exercise price of $0.64 per share, at an offering price of $0.64 per share of Common Stock and related Warrants,
for aggregate gross proceeds of $2,050,000.00. The Company issued to Rodman or its designees warrants to purchase up to an aggregate
of 160,156 shares of Common Stock,